Literature DB >> 1878461

Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic.

J Goshima1, V M Goldberg, A I Caplan.   

Abstract

It has been established that, when whole marrow is introduced into porous calcium phosphate ceramic, bone forms on the walls of the pores. To extend earlier studies, bone marrow cells derived from the femora of inbred rats were introduced into tissue culture and the adherent cells cultivated, mitotically expanded, passaged, harvested, placed in small cubes of porous calcium phosphate ceramics and grafted into subcutaneous sites of syngeneic rats. Marrow-derived, cultured mesenchymal cells introduced into ceramics showed strong osteogenic potential, with bone forming in the pore regions of ceramics as early as 2 wk after implantation. Osteogenesis could be observed after the eighteenth passage. With increasing passage number, the initiation of osteogenesis and the apparent rate of bone formation declined and the course of osteogenesis was delayed. In the future, it may be possible to culture marrow cells as a source for reparative cells for implantation back into autologous in vivo sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878461     DOI: 10.1016/0142-9612(91)90209-s

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects.

Authors:  Abigail M Wojtowicz; Kellie L Templeman; Dietmar W Hutmacher; Robert E Guldberg; Andrés J García
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

2.  Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice.

Authors:  Xiaoyun Xu; Nicole Geremia; Feng Bao; Anna Pniak; Melissa Rossoni; Arthur Brown
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

Review 3.  Induced membrane for treatment of critical sized bone defect: a review of experimental and clinical experiences.

Authors:  Jean-Charles Aurégan; Thierry Bégué
Journal:  Int Orthop       Date:  2014-07-02       Impact factor: 3.075

4.  Osteoblast response to zirconia-hybridized pyrophosphate-stabilized amorphous calcium phosphate.

Authors:  Bryce M Whited; Drago Skrtic; Brian J Love; Aaron S Goldstein
Journal:  J Biomed Mater Res A       Date:  2006-03-01       Impact factor: 4.396

Review 5.  Engineering bone: challenges and obstacles.

Authors:  D Logeart-Avramoglou; F Anagnostou; R Bizios; H Petite
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

6.  Fabrication and characterization of poly(DL-lactic-co-glycolic acid)/zirconia-hybridized amorphous calcium phosphate composites.

Authors:  Bryce M Whited; Aaron S Goldstein; Drago Skrtic; Brian J Love
Journal:  J Biomater Sci Polym Ed       Date:  2006       Impact factor: 3.517

7.  Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks.

Authors:  Luis A Solchaga; Kitsie J Penick; Jean F Welter
Journal:  Methods Mol Biol       Date:  2011

8.  Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.

Authors:  P Bianco; S A Kuznetsov; M Riminucci; L W Fisher; A M Spiegel; P G Robey
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 9.  Cell-based bone tissue engineering.

Authors:  Gert J Meijer; Joost D de Bruijn; Ron Koole; Clemens A van Blitterswijk
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Mesenchymal stem cells and porous β-tricalcium phosphate composites prepared through stem cell screen-enrich-combine(-biomaterials) circulating system for the repair of critical size bone defects in goat tibia.

Authors:  Wenxiang Chu; Yaokai Gan; Yifu Zhuang; Xin Wang; Jie Zhao; Tingting Tang; Kerong Dai
Journal:  Stem Cell Res Ther       Date:  2018-06-13       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.